Brachypterum eriocarpum
Brachypterum eriocarpum · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Brachypterum eriocarpum is a botanical species that has gained scientific interest due to its specific therapeutic potential. Research indicates that the stem of this plant contains bioactive compounds such as Alpinumisoflavone and various flavonoids. These chemical constituents are being studied for their significant antimetastatic activities in biological systems. Specifically, these substances show promise in addressing complex conditions like melanoma by influencing cell adhesion processes. Consequently, this plant represents a vital subject in the ongoing search for natural cancer-fighting agents.
- Synonyms
- Brachypterum Pseudorobustum · Derris Eriocarpa · 3 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Stem
Classification
Synonyms
Brachypterum eriocarpum is a plant species that is frequently identified by several different scientific names due to its complex taxonomic history. Within botanical literature, it is recognized by the synonym Brachypterum pseudorobustum. The plant has also been classified under the genus Derris, appearing as both Derris eriocarpa and Derris pseudorobusta. Furthermore, researchers have identified it through the synonyms Solori eriocarpa and Solori pseudorobusta. Understanding these various nomenclatural relationships is essential for maintaining accuracy in botanical studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Brachypterum eriocarpum belongs to the vast kingdom Plantae, representing the diverse life forms found within the botanical world. As a member of the genus Brachypterum, this species is specifically categorized under the class Equisetopsida. Its taxonomic journey continues through the order Fabales, which connects it to a wide array of related botanical structures. Furthermore, it is a distinguished member of the Fabaceae family, often recognized for its unique evolutionary traits. Understanding these hierarchical relationships provides essential insight into the biological identity of this fascinating plant.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Brachypterum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Brachypterum eriocarpum exhibits a diverse geographical range that spans across several key regions of Asia. In the temperate zones, the species is widely documented throughout various parts of China, including the South-Central and Southeast territories. Its presence extends into tropical climates as well, where it can be found across the Indian Subcontinent in areas such as Assam and the East Himalaya. Additionally, the plant's distribution reaches into the Indo-China region, specifically within Laos. This broad ecological footprint highlights the plant's ability to thrive in both temperate and tropical Asian environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Brachypterum eriocarpum, specifically through its major bioactive component alpinumisoflavone, exhibits significant antimetastatic activity against melanoma. Research indicates that this naturally occurring flavonoid effectively impairs the metastatic potential of human melanoma cells by promoting cellular differentiation. Furthermore, the compound inhibits critical processes such as cell adhesion, migration, and invasion. This inhibitory effect is achieved by modulating the miR-124/SPHK1 axis and reducing the expression of cyclooxygenase-2. Ultimately, these findings suggest that the plant's derivatives could serve as valuable antimetastatic agents in future cancer treatments.
Compounds
Brachypterum eriocarpum is a medicinal plant known to contain the significant bioactive flavonoid alpinumisoflavone. Recent research highlights the potential of this compound to serve as a potent antimetastatic agent, particularly in the treatment of melanoma. Studies demonstrate that alpinumisoflavone effectively impairs the metastatic potential of human melanoma cells by inhibiting their ability to adhere, migrate, and invade. This effect is achieved through the modulation of the miR-124/SPHK1 axis, which ultimately leads to a reduction in COX-2 expression. Consequently, these findings suggest that the components found within Brachypterum eriocarpum could play a vital role in future cancer therapies.
Conditions
Brachypterum eriocarpum, also known as Derris eriocarpa, contains bioactive compounds that demonstrate significant antimicrobial and antimetastatic properties. Specifically, certain isolated compounds from this plant exhibit inhibitory activities against the pathogens Candida albicans, Candida guilliermondii, and Microsporium gypseum. Furthermore, the flavonoid alpinumisoflavone derived from this species effectively inhibits cell adhesion in melanoma cells. This plant component also works to reduce cyclooxygenase-2 (COX-2) expression by modulating the miR-124/SPHK1 axis. These diverse biological activities highlight the plant's potential in treating both fungal infections and metastatic cancer.
Preparations
Parts used
Brachypterum eriocarpum, also identified in botanical studies as Derris eriocarpa, contains a stem that serves as a rich source of diverse chemical compounds. Researchers have successfully isolated several unique flavonoids and stilbenoids from this specific plant part using advanced spectroscopic techniques. These isolated substances, including new prenylisoflavones, have demonstrated significant antimicrobial activities against various fungal species. Furthermore, the compounds extracted from the stem exhibit potent antiproliferative effects on HeLa cells and strong antioxidant properties. This highlights the medicinal importance of the plant's stem in traditional ethnomedicine and modern pharmacological research.